MPH Health Care AG Total Liabilities
MPH Health Care AG total liabilities. Based on the latest financial reports, MPH Health Care AG (93M1) has total liabilities worth €14.68 Million EUR (≈ $17.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check MPH Health Care AG (93M1) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of MPH Health Care AG (2016–2025)
Total liabilities of MPH Health Care AG from 2016 to 2025. This chart illustrates how MPH Health Care AG's total liabilities have evolved over time, based on quarterly financial data.
MPH Health Care AG Competitors by Total Liabilities
The table below lists competitors of MPH Health Care AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bhiraj Office Leasehold Real Estate Investment Trust
BK:BOFFICE
|
Thailand | ฿2.56 Billion |
|
Action Electronics Co Ltd
TW:3024
|
Taiwan | NT$1.50 Billion |
|
CSC Steel Holdings Bhd
KLSE:5094
|
Malaysia | RM75.83 Million |
|
Mitrabara Adiperdana PT
JK:MBAP
|
Indonesia | Rp54.08 Million |
|
Global Fashion Group S.A
F:GFG
|
Germany | €353.40 Million |
|
DAE HWA Pharmaceutical Co. Ltd
KQ:067080
|
Korea | ₩134.61 Billion |
|
Bellevue Group AG
SW:BBN
|
Switzerland | CHF34.51 Million |
|
Titan Minerals Ltd
AU:TTM
|
Australia | AU$7.47 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down MPH Health Care AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MPH Health Care AG (93M1) total assets.
Liquidity & Leverage Metrics
MPH Health Care AG Total Liabilities Ratios Explained
MPH Health Care AG total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MPH Health Care AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MPH Health Care AG (2016–2025)
The table below shows the annual total liabilities of MPH Health Care AG from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €14.68 Million ≈ $17.16 Million |
+11.28% |
| 2024-12-31 | €13.19 Million ≈ $15.42 Million |
-14.26% |
| 2023-12-31 | €15.39 Million ≈ $17.99 Million |
-1.18% |
| 2022-12-31 | €15.57 Million ≈ $18.20 Million |
+173.66% |
| 2021-12-31 | €5.69 Million ≈ $6.65 Million |
-39.76% |
| 2020-12-31 | €9.45 Million ≈ $11.04 Million |
-56.07% |
| 2019-12-31 | €21.50 Million ≈ $25.14 Million |
+25.57% |
| 2018-12-31 | €17.13 Million ≈ $20.02 Million |
+2.47% |
| 2017-12-31 | €16.71 Million ≈ $19.54 Million |
+2.01% |
| 2016-12-31 | €16.38 Million ≈ $19.15 Million |
-- |
About MPH Health Care AG
MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology… Read more